<DOC>
	<DOCNO>NCT02760823</DOCNO>
	<brief_summary>The aim study evaluate efficacy safety Alpha Lipoic Acid ( ALA ) adjuvant management patient acute phosphide poisoning .</brief_summary>
	<brief_title>Alpha Lipoic Acid Adjuvant Treatment Acute Phosphide Poisoning</brief_title>
	<detailed_description>The study carry follow approval research ethical committee Tanta Faculty Medicine patient admit The Poison Control Unit ( Emergency Hospital , Tanta University Emergency Hospital , Mansoura University ) acute phosphide poisoning period January 2016 January 2018 . A write informed consent take patient his/her guardian ( patient unable participate consent process ) . Confidentiality data maintain make code number patient . The investigator plan conduct randomized clinical trial evaluate efficacy safety ALA adjuvant treatment patient acute phosphide poisoning . Fifty patient randomize ALA non ALA 1:1 ratio ( 25 patient group ) . ALA give IV , dose 600 mg/12 hour . Patients monitor detailed documentation adverse effect due ALA therapy record . This intervention represent added treatment exist standard care . All patient continue receive standard treatment , determine attend physician maintains clinical responsibility patient . It consist patient resuscitation , gastric decontamination ( sodium bicarbonate , activate charcoal [ 1 g/Kg , orally ] first 6 hour onset poison ) , adequate hydration supportive treatment . All patient follow discharge death . All patient subject : I . History . II . Clinical examination . III . Laboratory investigation : At admission repeat discharge .</detailed_description>
	<mesh_term>Poisoning</mesh_term>
	<mesh_term>Thioctic Acid</mesh_term>
	<criteria>Patients ( male female , age 12 year old ) symptomatic acute phosphide poisoning ( deliberate accidental ) , diagnosis make basis : 1 . The typical clinical manifestation due follow shortly single exposure phosphide . 2 . Reliable identification compound base container bring patient attendant subsequent confirmation silver nitrate test phosphine detection stomach content . Patients le 12 year age Pregnant lactating woman Patients ingestion exposure substances addition phosphide . Patients major medical condition ( e.g . cardiovascular disease , renal hepatic failure ) . Patients present 6 hour consume phosphide compound ( late presenter ) . Patients treat acute phosphide poison medical center admission .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>